The state-owned Jiban Bima Corporation (JBC) has tightened its underwriting criteria, explicitly barring individuals with pre-existing critical illnesses, those engaged in high-risk occupations, and applicants who withhold medical information from receiving supplementary insurance coverage, commonly known as riders. Under the new policy, all prospective policyholders seeking rider benefits must mandatorily submit comprehensive health information and verified medical test reports.
On 26 July, JBC issued a comprehensive directive containing 14 operational guidelines aimed at streamlining risk assessment and ensuring consistency across its network. The instruction has been formally circulated to all regional, corporate, sales, and branch offices for immediate and strict compliance.
Understanding Insurance Riders and New Eligibility Criteria
In commercial insurance, a rider is an optional benefit attached to a standard life insurance policy for an additional premium, expanding the base coverage. It functions as an extension of the primary contract rather than an independent policy. For instance, if an individual holding a basic life cover of ৳2 million opts for a ৳1 million accidental death rider, their designated beneficiary could receive up to ৳3 million in the event of an accidental fatality, subject to policy terms. JBC regularly offers various supplementary benefits alongside primary life policies, including health coverage, major disease protection, and waiver-of-premium provisions.
Under the newly issued regulations, rider facilities will be strictly reserved for healthy, active, and able-bodied individuals. Specific restrictions and guidelines introduced by JBC include:
-
Medical Disqualifications: Individuals suffering from pre-existing critical conditions—such as cancer, cardiovascular diseases, stroke, kidney failure, liver cirrhosis, or paralysis—are rendered ineligible. Coverage is likewise withheld from individuals with HIV/AIDS, severe congenital disorders, lifestyle-related complications, and chronic illnesses.
-
Mandatory Testing & Evaluation: Applicants must provide clinical test reports, including lipid profiles and serum creatinine levels, where required. JBC retains the right to demand supplementary diagnostic tests, formal medical certificates, or further health data. Furthermore, anyone admitted to a hospital or treated for a severe ailment within the past two years will not qualify without a thorough medical evaluation.
-
Occupational & Physical Exclusions: Individuals with permanent or partial physical or mental disabilities are excluded from health, major illness, and waiver-of-premium benefits. Similarly, those working in high-risk professions, engaging in dangerous sports, or participating in hazardous occupations will be denied supplementary coverage.
-
Impact of Policy Status: Because rider benefits remain intrinsically linked to the underlying life policy, any cancellation, surrender, or lapsation of the main contract automatically terminates the associated rider coverage.
Mitigating Non-Disclosure and Operational Discrepancies
A central emphasis of the 14-point directive is full disclosure. Policyholders are legally obligated to declare their complete medical history, previous treatments, and professional medical advice. Intentionally withholding health details or providing fraudulent information will result in the immediate rejection of insurance claims, accompanied by legal and regulatory remedies.
This regulatory overhaul follows widespread operational inconsistencies across JBC branches. Officiating Managing Director Sayeed Khutub—who also serves as an Additional Secretary at the Financial Institutions Division under the Ministry of Finance—stated that the primary objective of these rules is to curb fraudulent practices. Field-level reports indicate that numerous branch offices had previously approved rider applications without conducting requisite medical checks or assessing occupational risks, leading to severe discrepancies. Consequently, several claims faced outright rejection upon settlement disputes due to suppressed health details or underlying ineligibility.
This institutional reform comes during a period of leadership transition at the corporation. JBC Chairman Md. Mokhles ur Rahman tendered his resignation recently, which is currently awaiting approval from the Prime Minister’s Office, whilst the state enterprise operates without a permanent managing director. Authorities anticipate that these unified guidelines will standardise risk assessment, foster transparency in claim settlements, and substantially reduce legal disputes arising from non-disclosure.